pharmacology Flashcards
trimethoprim/sulfamethoxazole formulations use what ratio of dose between trimethoprim and sulfamethoxazole
1:5 ratio, so trimethoprim is less than sulfamethoxazole
(just remember trimethoprim has less letters)
usually its 4+20
denosumab - counselling points (5)
- 6 monthly dosing
- missing a dose by more than 4 weeks can lead to multiple spontaneous vertebral fractures
- if stopping, needs to be switched to a bisphosphonate
- can cause hypocalcaemia
- must maintain calcium and vit d status
oral bisphosphonates - counselling points (3)
- oral formulations can cause GI upset
- absorption reduced by food, antacids, calcium, magnesium and iron
- can cause osteonecrosis of the jaw - see dentist beforehand)
zoledronic acid - adverse effects (4)
transient influenza-like symptoms
uveitis (uncommon)
osteonecrosis of jaw
hypocalcaemia
valaciclovir
- indications and dosage regimen (3)
genital herpes - initial infection - 500mg BD for 5-10 days - recurrent infection - 500mg BD for 3 days - prophylaxis - 500mg OD recurrent cold sores - 2g every 12 hours, 2 doses shingles 1g PO TDS for 7 days
apixaban
- indications and dosage (3)
VTE prophlyaxis after hip/knee replacement
- 2.5mg BD, 10-14 days (knee) or 32-38 days (hip)
prophylaxis in AF
- 5mg BD
venous thromboembolism
- 10mg BD for 7 days, then 5mg BD for 3-6 months
indomethacin - PR suppository dose
100mg BD
pyridostigmine , neostigmine
- mode of action
- indications (2)
mode of action
- cholinergic
- inhibits cholinesterase enzymes -> more acetylcholine floating around to do neurotransmitting
indications
- myasthenia gravis
- reversing a neuromuscular blockade by neuromuscular blockers
suxamethonium
- mode of action
- indications (1)
acts like acetylcholine, neuromuscular blockade by binding to acetylcholine receptors
relax muscles during anaesthesia
atropine
- mode of action
- indications (2)
anticholinergic
bradycardia
blocks muscarinic side effects of neostigmine and pyridostigmine
hyoscine
- which version crosses blood-brain barrier
hyoscine hydrobromide crosses blood brain barrier
hyoscine
- which version is preferred in palliative care
- why
hyoscine butylbromide
less likely to cause CNS side effect
hyoscine butylbromide
- mechanism of action
- indication in pall care
- anticholinergic
- reduce secretions
lithium toxicity - presenting signs and symptoms
- GI (3)
- neuro (4 mild-mod, 3 severe)
- cardiac (2)
GI
- nausea
- vomiting
- diarrhea
neuro (mild to moderate) - tremors - hyperreflexia - dysarthria - ataxia neuro (severe) - confusion - coma - seizures
Cardiac
- QT prolongation
- hypotension
lithium toxicity - risk factors
- pmhx (3)
- pharm (1)
- personal (2)
pmhx
- nephrogenic diabetes insipidus
- hypothyroidism
- renal impairment
pharm
- new medications that affect renal fxn
personal
- age > 50
- poor hydration